Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 7:00 PM View:  | Kontulis Caitlin Secretary & VP Finance & Admin | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-24 | Payment of Exercise | 335 | $0.96 | $320.93 | (3%) 10.98K to 10.64K | (100%) |
| 27-Feb-24 4:42 PM View: | Bitterman Robert J President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 26-Feb-24 | Market Purchase | 2,500 | $0.91 | $2,275.00 | 15% 16.49K to 18.99K | (100%) |
| 22-Feb-24 7:00 PM View: | Bitterman Robert J President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 20-Feb-24 | Payment of Exercise | 1,804 | $0.76 | $1,371.04 | (10%) 18.29K to 16.49K | |
| 20-Feb-24 7:03 PM View: | Kontulis Caitlin Secretary & VP Finance & Admin | Phio Pharmaceuticals Corp. (PHIO) | 17-Feb-24 | Payment of Exercise | 523 | $0.66 | $345.18 | (5%) 11.5K to 10.98K | |
| 20-Feb-24 7:03 PM View: | Kontulis Caitlin Secretary & VP Finance & Admin | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-24 | Payment of Exercise | 658 | $0.65 | $427.70 | (5%) 12.16K to 11.5K | |
| 03-Oct-23 10:00 PM View: | Bitterman Robert J President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Oct-23 | Payment of Exercise | 917 | $1.51 | $1,384.67 | (5%) 19.21K to 18.29K | |
| 05-Jul-23 6:00 PM View: | Bitterman Robert J President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Jul-23 | Purchase | 1,000 | $2.84 | $2,840.00 | 5% 18.21K to 19.21K | |
| 05-Jul-23 6:00 PM View: | Bitterman Robert J President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 30-Jun-23 | Purchase | 1,000 | $2.88 | $2,880.00 | 6% 17.21K to 18.21K | |
| 15-Jun-23 5:00 PM View: | Ferrara Robert L Director | Phio Pharmaceuticals Corp. (PHIO) | 14-Jun-23 | Purchase | 2,000 | $3.10 | $6,200.00 | 50% 4.0K to 6.0K | |
| 03-Mar-23 6:00 PM View: | Kontulis Caitlin Secretary & VP Finance & Admin | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-23 | Payment of Exercise | 335 | $5.49 | $1,839.15 | (3%) 12.49K to 12.16K | |
| 22-Feb-23 7:00 PM View: | Bitterman Robert J President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 20-Feb-23 | Grant | 11,000 | -- | -- | 177% 6.21K to 17.21K | |
| 22-Feb-23 7:25 PM View: | Freeman Jonathan E Director | Phio Pharmaceuticals Corp. (PHIO) | 17-Feb-23 | Grant | 1,500 | -- | -- | 88% 1.7K to 3.2K | |
| 22-Feb-23 7:15 PM View: | Cauwenbergh Geert Director | Phio Pharmaceuticals Corp. (PHIO) | 17-Feb-23 | Grant | 1,500 | -- | -- | 55% 2.73K to 4.24K | |
| 22-Feb-23 7:30 PM View: | Lockshin Curtis Director | Phio Pharmaceuticals Corp. (PHIO) | 17-Feb-23 | Grant | 1,500 | -- | -- | 88% 1.7K to 3.2K | |
| 22-Feb-23 7:10 PM View: | Bradford Patricia A Director | Phio Pharmaceuticals Corp. (PHIO) | 17-Feb-23 | Grant | 1,500 | -- | -- | 90% 1.67K to 3.17K | |
| 22-Feb-23 7:05 PM View: | Kontulis Caitlin Secretary & VP Finance & Admin | Phio Pharmaceuticals Corp. (PHIO) | 17-Feb-23 | Grant | 4,500 | -- | -- | 56% 7.99K to 12.49K | |
| 22-Feb-23 7:20 PM View: | Ferrara Robert L Director | Phio Pharmaceuticals Corp. (PHIO) | 17-Feb-23 | Grant | 1,500 | -- | -- | 60% 2.5K to 4.0K | |
| 17-Feb-23 6:30 PM View: | Kontulis Caitlin Secretary & VP Finance & Admin | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-23 | Payment of Exercise | 657 | $5.20 | $3,416.40 | (8%) 8.65K to 7.99K | |
| 15-Dec-22 5:00 PM View: | Bitterman Robert J Interim Executive Chairman Director | Phio Pharmaceuticals Corp. (PHIO) | 14-Dec-22 | Private Purchase | 2,000 | $0.39 | $780.00 | 3% 72.54K to 74.54K | |
| 08-Dec-22 4:30 PM View: | Bitterman Robert J Interim Executive Chairman Director | Phio Pharmaceuticals Corp. (PHIO) | 07-Dec-22 | Private Purchase | 2,000 | $0.39 | $780.00 | 3% 70.54K to 72.54K | |
| 06-Dec-22 4:30 PM View: | Bitterman Robert J Interim Executive Chairman Director | Phio Pharmaceuticals Corp. (PHIO) | 05-Dec-22 | Private Purchase | 2,000 | $0.43 | $860.00 | 3% 68.54K to 70.54K | |
| 05-Dec-22 4:30 PM View: | Ferrara Robert L Director | Phio Pharmaceuticals Corp. (PHIO) | 02-Dec-22 | Private Purchase | 5,000 | $0.41 | $2,041.00 | 20% 25.0K to 30.0K | |
| 29-Nov-22 4:30 PM View: | Bitterman Robert J Interim Executive Chairman Director | Phio Pharmaceuticals Corp. (PHIO) | 29-Nov-22 | Purchase | 215 | $0.40 | $86.00 | < 1% 68.33K to 68.54K | |
| 29-Nov-22 4:30 PM View: | Bitterman Robert J Interim Executive Chairman Director | Phio Pharmaceuticals Corp. (PHIO) | 25-Nov-22 | Private Purchase | 2,500 | $0.42 | $1,050.00 | 4% 65.83K to 68.33K | |
| 28-Nov-22 4:30 PM View: | Ferrara Robert L Director | Phio Pharmaceuticals Corp. (PHIO) | 23-Nov-22 | Private Purchase | 2,000 | $0.41 | $819.80 | 9% 23.0K to 25.0K | |
| 16-Nov-22 5:06 PM View: | Bitterman Robert J Interim Executive Chairman Director | Phio Pharmaceuticals Corp. (PHIO) | 16-Nov-22 | Purchase | 1 | $1,750.00 | $1,750.00 | 100% 0 to 1 | |
| 03-Oct-22 8:01 PM View: | Bitterman Robert J Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Oct-22 | Grant | 40,000 | -- | -- | 155% 25.83K to 65.83K | |
| 26-Sep-22 7:00 PM View: | Bradford Patricia A Director | Phio Pharmaceuticals Corp. (PHIO) | 09-Aug-22 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 03-Mar-22 7:13 PM View: | Kontulis Caitlin Secretary & VP Finance & Admin | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-22 | Payment of Exercise | 4,011 | $0.82 | $3,293.03 | (4%) 107.83K to 103.81K | (100%) |
| 03-Mar-22 7:12 PM View: | Dispersyn Gerrit President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-22 | Payment of Exercise | 8,954 | $0.82 | $7,351.23 | (4%) 221.28K to 212.33K | (100%) |
| 16-Feb-22 8:06 PM View: | Ferrara Robert L Director | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-22 | Grant | 10,000 | -- | -- | 77% 13.0K to 23.0K | |
| 16-Feb-22 8:01 PM View: | Cauwenbergh Geert Director | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-22 | Grant | 10,000 | -- | -- | 44% 22.82K to 32.82K | |
| 16-Feb-22 7:59 PM View: | Bitterman Robert J Director | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-22 | Grant | 10,000 | -- | -- | 63% 15.83K to 25.83K | |
| 16-Feb-22 8:03 PM View: | Dispersyn Gerrit President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-22 | Grant | 126,000 | -- | -- | 132% 95.28K to 221.28K | |
| 16-Feb-22 8:12 PM View: | Lockshin Curtis Director | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-22 | Grant | 10,000 | -- | -- | 96% 10.37K to 20.37K | |
| 16-Feb-22 8:10 PM View: | Kontulis Caitlin Secretary & VP Finance & Admin | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-22 | Grant | 68,000 | -- | -- | 171% 39.83K to 107.83K | |
| 16-Feb-22 8:08 PM View: | Freeman Jonathan E Director | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-22 | Grant | 10,000 | -- | -- | 96% 10.36K to 20.36K | |
| 16-Feb-22 8:05 PM View: | Dorman H. Paul Director | Phio Pharmaceuticals Corp. (PHIO) | 15-Feb-22 | Grant | 10,000 | -- | -- | 96% 10.37K to 20.37K | |
| 17-Aug-21 9:11 AM View: | Dispersyn Gerrit President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 16-Aug-21 | Market Purchase | 6,000 | $1.63 | $9,780.00 | 7% 89.28K to 95.28K | (100%) |
| 05-Mar-21 7:05 AM View: | Dispersyn Gerrit President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 04-Mar-21 | Market Purchase | 1,953 | $2.56 | $4,999.68 | 2% 87.33K to 89.28K | (100%) |
| 03-Mar-21 9:00 PM View: | Dispersyn Gerrit President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 03-Mar-21 | Market Purchase | 2,500 | $3.03 | $7,575.00 | 3% 84.83K to 87.33K | |
| 03-Mar-21 9:05 PM View: | Ferrara Robert L Director | Phio Pharmaceuticals Corp. (PHIO) | 03-Mar-21 | Market Purchase | 682 | $3.15 | $2,148.30 | 6% 12.32K to 13.0K | |
| 03-Mar-21 9:05 PM View: | Bitterman Robert J Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-21 | Grant | 10,000 | -- | -- | 172% 5.83K to 15.83K | |
| 03-Mar-21 9:00 PM View: | Dispersyn Gerrit President & CEO Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-21 | Grant | 68,450 | -- | -- | 418% 16.38K to 84.83K | |
| 03-Mar-21 9:05 PM View: | Lockshin Curtis Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-21 | Grant | 10,000 | -- | -- | 2732% 0.37K to 10.37K | |
| 03-Mar-21 9:00 PM View: | Kontulis Caitlin Secretary & VP Finance & Admin | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-21 | Grant | 34,600 | -- | -- | 662% 5.23K to 39.83K | |
| 03-Mar-21 9:05 PM View: | Freeman Jonathan E Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-21 | Grant | 10,000 | -- | -- | 2747% 0.36K to 10.36K | |
| 03-Mar-21 9:05 PM View: | Dorman H. Paul Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-21 | Grant | 10,000 | -- | -- | 2703% 0.37K to 10.37K | |
| 03-Mar-21 9:05 PM View: | Ferrara Robert L Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-21 | Grant | 10,000 | -- | -- | 431% 2.32K to 12.32K | |
| 03-Mar-21 9:05 PM View: | Cauwenbergh Geert Director | Phio Pharmaceuticals Corp. (PHIO) | 01-Mar-21 | Grant | 10,000 | -- | -- | 78% 12.82K to 22.82K |
